Predicting success of vagus nerve stimulation (VNS) from interictal EEG  by de Vos, C.C. et al.
Seizure 20 (2011) 541–545Predicting success of vagus nerve stimulation (VNS) from interictal EEG
C.C. de Vos a,b,*, L. Melching a, J. van Schoonhoven a, J.J. Ardesch b, A.W. de Weerd c, H.C.E. van Lambalgen c,
M.J.A.M. van Putten a,b
aMIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, The Netherlands
bDepartment of Clinical Neurophysiology, Medisch Spectrum Twente, The Netherlands
c SEIN Epilepsie Instellingen, Zwolle, The Netherlands
A R T I C L E I N F O
Article history:
Received 20 October 2010
Received in revised form 3 March 2011
Accepted 1 April 2011
Keywords:
Epilepsy
Quantitative electroencephalography
(qEEG)
Brain symmetry index (BSI)
Vagus nerve stimulation (VNS)
A B S T R A C T
Purpose: Vagus nerve stimulation (VNS) has shown to be an effective treatment for drug resistant
epilepsy in numerous patients, however, not in all. It is still not possible to predict which patients will
proﬁt from VNS. In this pilot study, we explore predictive interictal EEG features for seizure reduction
after VNS.
Methods: 19 Patients with medically refractory epilepsy and an implanted VNS system were included.
Interictal EEG registrations, recorded before implantation, were retrospectively analysed. A quantative
symmetry measure, the pair wise derived brain symmetry index (pdBSI), was tested to predict VNS
outcome. Reduction in seizure frequency was used to deﬁne the responders.
Results: 10 Patients did respond to VNS, of whom 7 patients had a seizure reduction of at least 50% in a
follow-up period of 2 years. On average, we ﬁnd higher pdBSI values for delta, theta, alpha and beta bands
for non-responders than for responders. The average pdBSI of the theta and alpha bands could
signiﬁcantly discriminate between responders and non-responders.
Conclusion: In this study, quantifying EEG symmetry using the pdBSI shows promising results in
predicting the reduction of seizure frequency after VNS treatment.
 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Vagus nerve stimulation (VNS) has shown to be an effective
treatment for epilepsy in numerous patients. Most long-term
studies that were done to assess the efﬁcacy of VNS concluded that
a more than 50% seizure reduction was accomplished in 20–55% of
the patients after treatment for six months to six years.1–3
According to Janszky et al.,4 0–24% of the medically refractory
patients treated with VNS becomes seizure free.
Despite the growing application of VNS, it is still not possible to
predict which patients respond to what extent to VNS therapy.
Determining the success of VNS is important to counsel patients
and give them information about the expected seizure reduction.
Potential responders might not need to try other kinds of therapy
before they receive an effective VNS system and on the other hand,
a low likelihood to respond could prevent someone from having an
expensive VNS system implanted while only minimal effects will
be obtained.* Corresponding author at: Medisch Spectrum Twente, Department of Clinical
Neurophysiology, P.O. Box 50,000, 7500 KA Enschede, The Netherlands.
Tel.: +31 53 487 3532; fax: +31 53 487 2816.
E-mail address: c.devos@mst.nl (C.C. de Vos).
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doi:10.1016/j.seizure.2011.04.002Most studies that attempt to predict the success of VNS are
based upon the localization of the seizure focus, patient
characteristics or epilepsy syndrome. However, predictors of
success are still elusive. It was found that VNS responsiveness
was associated with older age and longer epilepsy duration5 or
rather to be independent of epilepsy duration6 and associated with
younger age.7 VNS success was found to be related to epilepsy
syndromes other than Lennox-Gastaut syndrome5 or rather to
Lennox-Gastaut syndrome3,8 and tonic seizures.3 Furthermore,
Scherrmann et al.9 concluded that seizure outcome was positively
correlated with VNS duration and Handfort et al.10 found that
seizure reduction was positively correlated with high stimulation
settings.
Until now, very few studies evaluated whether success of VNS
can be forecasted using the electroencephalogram (EEG).4,11 There
are some more epilepsy surgery studies using EEG as a tool to
assess outcome prognosis.12–14 These studies are all primarily
based on the visual analysis of the EEG, for instance by counting the
number of Interictal Epileptic Discharges (IED) before onset of the
therapy. Janszky et al.4 showed that absence of bilateral IEDs in the
EEG before VNS implantation was associated with a seizure free
outcome.
However, observing the different wave-forms in the EEG is
subjective and laborious because the results depend on thevier Ltd. All rights reserved.
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tative EEG (qEEG) analysis may partially replace the visual
interpretation15–17 and is a more objective and perhaps sensitive
method than visual interpretation of EEG. qEEG may even detect
characteristics of the EEG that are not visible for the naked eye, like
synchronization measures, power per frequency band and
symmetry measures.
We hypothesize that symmetry can be a relevant feature to
predict the effect of VNS therapy. Van Putten18,19 originally
proposed the brain symmetry index (BSI) as a measure for
electroencephalographic symmetry. The BSI quantiﬁes the spatial
EEG symmetry and has found clinical applications for the
detection of (focal) ischemia20,21 and focal seizure activity.22
We hypothesize that the interictal EEG from patients suffering
from (multi-focal) pharmacoresistant epilepsy may be character-
ized by an increased asymmetry. This is motivated by the
observation that in many of these patients, the interictal EEG
often shows asymmetric features, e.g. focal slowing or amplitude
asymmetries. In this study, therefore, we explore whether
baseline EEG symmetry, as quantiﬁed by the BSI, is a predictor
for success of VNS therapy.
2. Materials and methods
2.1. Patient selection
VNS treated patients were selected retrospectively (see Table
1). All patients suffered from (multi) focal, medically intractable
epilepsy with varying focus locations and were scheduled for
implantation of a vagus nerve stimulator (Cyberonics, Houston,
TX) between 2001 and 2008. All patients were treated at the
epilepsy centre SEIN Zwolle. Patients were aged 16 years or older
and should have had an EEG recorded shortly before the onset of
VNS therapy. During this EEG recording, no epileptic seizure
should have occurred, as the interictal EEG pattern is analysed and
sufﬁcient minutes of artefact free EEG should be available. Three
months prior to implantation and during the ﬁrst year after
implantation anticonvulsant drug intake should have been
unchanged.
Patients and their family should have kept seizure diaries for
over six months prior to the VNS therapy and during the ﬁrst one to
two years of VNS therapy. The evaluated seizure reduction during
therapy was used to determine the success of VNS. The average
number of seizures per month was calculated and two deﬁnitions
were used to deﬁne responders. Responders0 were deﬁned asTable 1
Patient characteristics at onset of vagus nerve stimulation.
No. Sex Age (y) Type epilepsy Effect VNS (% reduc
1 M 30 Focal 0 
2 M 47 Multifocal 50 
3 F 56 Focal 60 
4 M 16 Multifocal 0 
5 M 21 Multifocal 0 
6 M 50 Focal 25 
7 F 55 Focal 80 
8 F 46 Focal 0 
9 F 33 Focal 30 
10 F 31 Multifocal 0 
11 M 41 Focal 60 
12 F 63 Focal 0 
13 M 42 Focal 0 
14 F 39 Focal 50 
15 F 47 Focal 50 
16 M 64 Focal 80 
17 M 45 Focal 25 
18 M 29 Focal 0 
19 M 16 Focal 0 having any reduction in seizure frequency and responders50 had at
least 50% seizure reduction.
The stimulation parameters are personalized for each patient.
Often the therapy started with a stimulation cycle of 30 s on and
5 min off. The amplitude was increased guided by the effects and
side-effects of the stimulation. When further increase of the
amplitude was neither effective nor possible, a more rapid
stimulation cycle was tested.
2.2. EEG analysis
All EEGs were recorded by trained personnel at the SEIN
epilepsy centre. Electrodes were placed according to the 10/20
system, ﬁxed by adhesive and conductive gel. Impedances did not
exceed 10 kV. Sampling frequency was 200 Hz. Twenty to forty
minutes of EEG were recorded, according to standard protocol,
containing periods of hyperventilation, eyes closed, eyes open,
intermittent photo stimulation and somatosensory stimulation of
the hand.
Source reference was used for montage and only periods of
closed eyes without any form of stimulation were used for analysis.
This was done to avoid qEEG abnormalities due to eye movements
or other provocations. Furthermore, periods with IEDs, movement
artefacts or periods indicating drowsiness were excluded after
visual inspection. At least several minutes of artefact free EEG
activity with closed eyes needed to be present for an EEG recording
to be analysed. Selected epochs were subsequently ﬁltered with a
band pass ﬁlter between 0.5 and 30 Hz. Epochs of 400 samples with
50% overlap were Fourier transformed with pwelch in MATLAB
(The MathWorks, Inc.) using a Hamming window.
2.3. Features
A new implementation of the BSI was used for analysing brain
symmetry. Originally the BSI was proposed as a measure for the
mean electroencephalographic spatial symmetry of the brain.19
More recently, the pdBSI was introduced by Sheorajpanday et al.21
as a natural extension of the BSI. The pdBSI is a single channel pair
wise derived BSI which evaluates asymmetry along homologous
channel pairs instead of global asymmetry, which is measured
with the BSI. Comparison of homologous channel pairs (pdBSI)
instead of global hemispheric differences (BSI) could lead to a more
sensitive determination of abnormal asymmetry in epilepsy
patients with several or cryptogenic foci. The pdBSI21 is calculated
with:tion) pdBSId baseline pdBSIt baseline pdBSIa baseline
0.330 0.304 0.292
0.320 0.288 0.303
0.320 0.295 0.281
0.312 0.306 0.300
0.339 0.327 0.320
0.289 0.287 0.304
0.308 0.286 0.292
0.441 0.435 0.395
0.370 0.342 0.370
0.398 0.364 0.325
0.299 0.267 0.271
0.273 0.233 0.243
0.332 0.354 0.326
0.278 0.272 0.281
0.287 0.269 0.259
0.322 0.296 0.302
0.322 0.281 0.335
0.340 0.308 0.306
0.311 0.307 0.315
Table 2
p-Values for discrimination between responders and non-responders, based on pair
wise derived brain symmetry values (pdBSI) for different frequency bands extracted
from EEGs recorded before the onset of VNS treatment.
pdBSI (delta, theta, alpha, beta)
pdBSId pdBSIt pdBSIa pdBSIb
Non-responders0 vs. responders0 0.09 0.01
* 0.31 0.94
Non-responders50 vs. responders50 0.07 0.06 0.02
* 0.14
* p-Value < 0.05.
Fig. 1. Differences between (a) responders50 (n = 7) and non-responders50 (n = 12)
and (b) responders0 (n = 10) and non-responders0 (n = 9) in pdBSI for the delta,
theta, alpha and beta band, extracted from EEGs recorded before onset of VNS
treatment. Error bars represent the standard deviation. *p < 0.1, **p < 0.05.
C.C. de Vos et al. / Seizure 20 (2011) 541–545 543pdBSI ¼ 1
N
XK
i¼1
1
M
XM
j¼1
Ri; j  Li; j
Ri; j þ Li; j


With Ri,j and Li,j the Fourier coefﬁcient belonging to frequency
i = 1, . . ., K of right and left hemispheric bipolar derivations j = 1, 2,
. . ., M for N discrete time points. The bipolar derivations used to
calculate the pdBSI are Fp1–Fp2, F3–F4, F7–F8, F9–F10, C3–C4, P3–
P4, P7–P8, O1–O2, T7–T8.
The BSI is deﬁned in such a way that the lower the BSI, the
higher the EEG symmetry. EEG recordings from ‘‘normal healthy
brains’’ result in BSI values of about 0.0719 and pdBSI values of
about 0.13.21 Increased pdBSI values are obtained if EEG recordings
show asymmetries, e.g. focal slowing or differences in amplitudes
of homologous channel pairs.
Four different frequency ranges were explored: delta (0.5–
4 Hz), theta (4–8 Hz), alpha (8–12 Hz) and beta (12–30 Hz). Higher
frequency ranges were not investigated because of the low signal
to noise ratio for these frequencies when using scalp EEG.
2.4. Statistics
For the discrimination between responders and non-respon-
ders based on single features, t-tests were applied when data was
normally distributed; Mann–Whitney U tests were used when data
was not normally distributed. Normality tests were done for all
single features using the Shapiro Wilk test. A conﬁdence interval of
95% was used to deﬁne signiﬁcant results. This current study was
used to discover promising features that will be tested extensively
in our future study.
3. Results
The EEG recordings of only 19 patients matched our inclusion
criteria and were analysed. These EEGs were recorded within an
interval of six weeks prior to onset of the VNS therapy and
contained only few artefacts. The patients included were 11 men
and 8 women, with a mean age of 45 years (standard deviation 15
years). 15 patients suffered from focal epilepsy, while 4 had multi
focal epilepsy. Due to VNS therapy, 10 patients obtained a
reduction in seizure frequency (responders0) of which 7 had a
reduced seizure frequency of at least 50% (responders50). For all
patients, the pdBSI values of all frequency bands were obviously
increased compared to the average value of 0.13 for healthy control
subjects measured by Sheorajpanday et al.21 (see Table 1). This
indicates that before treatment with VNS, the asymmetry of the
EEG activity for all the patients is signiﬁcantly higher than for
healthy controls.
Table 2 shows the p-values for the discrimination between
responders0 and non-responders0 and between responders50 and
non-responders50 using the pdBSI for the different frequency
bands. A lower pdBSI value indicates more symmetry along
homologous channel pairs of the two hemispheres. The pdBSI for
the theta band (pdBSIt) is signiﬁcantly lower for responders0 than
for non-responders0 and the pdBSI for the delta band (pdBSId)
shows a difference between responders0 and non-responders0 as
well, however this difference is less convincing. The pdBSI for the
alpha band (pdBSIa) is signiﬁcantly lower for responders50 than for
non-responders50 and both the pdBSId and pdBSIt also show clear
differences between responders50 and non-responders50.
Fig. 1 shows the pdBSI values for responders50 and responders0
for the four different frequency bands. Responders have on average
lower pdBSI values for all frequency ranges than non-responders,
independent of the deﬁnition of responders. Relatively low BSI
values for responders imply that, prior to the onset of VNS
treatment, symmetry in the EEG is yet higher for responders than
for non-responders.Results show that responders50 have slightly lower BSI values
than responders0. In addition, the variance in the pdBSI of the non-
responders is in general much larger than the variance in the pdBSI
of the responders. Differences between responders50 and non-
responders50 are larger than between responders0 and non-
responders0.
4. Discussion
In this study, we evaluate particular symmetry measures of the
EEG in their ability to predict whether patients will respond with a
seizure reduction to vagus nerve stimulation. It is found that local
symmetry values (pdBSI), especially for the delta, theta and alpha
frequency ranges, correlate with a positive response to VNS
treatment. Although in patients the pdBSI values are higher than in
healthy controls, non-responders have signiﬁcantly higher pdBSI
values before the onset of VNS treatment than responders.
In many patients suffering from epilepsy, in particular focal
seizures, the interictal EEG may show local abnormalities, e.g. focal
C.C. de Vos et al. / Seizure 20 (2011) 541–545544slowing or differences in amplitude, which will increase the pdBSI
values. In this study, we indeed found that for all patients the pdBSI
values are higher than for healthy controls. In addition, non-
responders showed signiﬁcantly higher pdBSI values than respon-
ders. This suggests that in patients with only mildly abnormal
EEGs, as reﬂected by the moderate increases in the pdBSI, VNS is
more likely to have a clinically relevant effect. As the amount of
asymmetry as quantiﬁed by the pdBSI, may indeed reﬂect the
deviation from normal, VNS seems relatively more effective in mild
cases.
It was also found that, using the BSI to quantify hemispheric
symmetry, we can better predict whether a patient will have a
seizure reduction of more than 50% (responder50), than that we can
predict any seizure reduction at all (responder0). Patients who
have experienced a seizure reduction of less than 50% were
patients with limited response to the therapy. Including these
poor-responders in a statistical analysis decreases the power.
Although our study population is too small to differentiate
between more gradual responses, it appears that brain symmetry
values are most suited to identify the best responders.
Anticonvulsant drugs may inﬂuence several characteristics of
the EEG. The patients in this study all used combinations of two to
four different anticonvulsant drugs. Many patients used combina-
tions including valproic acid, carbamazepine or lamotrigine.
However, the effects of anticonvulsants on the EEG are typically
minor and global rather than focal, e.g. a minimal reduction in
alpha mean frequency.23 Therefore, the effect of anticonvulsants
on the BSI will be minimal, if present at all. Indeed, a correlation
between pdBSI values and particular anticonvulsant drugs was not
found.
Evaluation of the interictal EEG to predict success of vagus
nerve simulation was previously brieﬂy described by Majoie
et al.11 who mentioned a lower average background frequency and
more interictal epileptiform abnormalities in patients who did not
respond to VNS treatment. The obtained difference in background
frequency in their study was however not statistically signiﬁcant.
Research done by Janszky et al.4 showed that the absence of
bilateral IEDs predicted success of VNS treatment. Quantiﬁcation
of the EEG patterns in both previous studies was difﬁcult, as the
authors used primarily visual inspection of the EEG recordings,
whereas our approach is also feasible when there are no IEDs
visible and allows more objective quantiﬁcation of predictive EEG
characteristics.
Various related studies used qEEG features to evaluate VNS
therapy, rather than to predict its effects.24–26 In these studies of
the interictal EEG, low EEG frequencies (i.e. delta–theta–alpha)
have been found to be most relevant, and associated with various
epilepsy syndromes. Novak et al.26 found that the chronic effect of
VNS on the interictal EEG showed a trend towards decreased delta
power and increased alpha power. Marrosu et al.25 investigated
background interictal EEG in awake epilepsy patients after therapy
as well. They evaluated both changes in the power spectrum and
the synchronization level using the cross spectral density function
normalized by individual auto-spectral density functions.27 In
eleven subjects, the intra- and inter-hemispheric synchronization
in the theta band (4–7.5 Hz) both decreased, whereas the power of
the gamma band (20–50 Hz) and the intra-hemispheric synchro-
nization increased. Since evaluation of qEEG changes is very
relevant and may provide important information about potential
mechanisms of VNS therapy, we have also studied qEEG changes
due to VNS therapy. However, this is beyond the scope of this
paper. We have chosen to focus on prediction, as predicting the
response to VNS will provide great clinical beneﬁts. Determining
features that will predict potential responders and provide
patients with information about the expected seizure reduction
will increase the efﬁcacy of VNS therapy.This study is a ﬁrst exploration of predictive qEEG features to
identify responders to VNS therapy. Although we were not able to
predict the effect of VNS for the individual patient, EEG symmetry
quantiﬁed by pdBSI seems a relevant feature. Additional validation
of the proposed BSI features and the creation of a prediction model
are subjects of our future study.
5. Conclusion
In sum, our study shows that EEG symmetry features may be
useful to predict the success of VNS therapy. Brain symmetry index
values in the different frequency bands show that patients who
will not respond to VNS treatment have, on average, more
asymmetric spectral characteristics of the interictal EEG than
responders.
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